Furthermore, our multivariate survival analysis including major clinical and pathological features revealed that the RAP2A expression is independently associated with poor overall survival, disease-specific survival, and progression-free interval in HCC. This evidence concerns the gene RAP2A and hepatocellular carcinoma.